Anxiety and depression are highly prevalent in chronic kidney disease. In recent years, we’ve learned that response to antidepressants is different in patients with kidney disease. This, coupled with altered medication risk profiles due to declining kidney function, makes management of anxiety and depression a considerable challenge. This module provides an overview of pharmacologic and non-pharmacologic treatment options for anxiety and depression unique to patients with kidney disease.
Heather Legris, PharmD, BCPS
Medication Therapy Management Pharmacist, Hennepin Healthcare's Coordinated Care Center
Dr. Heather Legris is a Medication Therapy Management pharmacist in Minneapolis at Hennepin Healthcare's Coordinated Care Center — a primary care clinic that utilizes a multidisciplinary approach to care for patients with significant medical and psychosocial complexities. Dr. Legris earned her Doctor of Pharmacy from the University of Washington and completed a pharmacy practice residency at Harborview Medical Center in Seattle. Prior to her current role as an MTM pharmacist, she spent many years as a clinical specialist in inpatient psychiatry.
